litlas
Log inCreate account

Jianping Weng

Active 1999–2025

147
Papers
19,664
Citations
65
h-index
130
i10-index

Citations

Citations per year for Jianping Weng1987: 1 citations1996: 1 citations2000: 3 citations2001: 7 citations2002: 6 citations2003: 5 citations2004: 1 citations2005: 4 citations2006: 4 citations2007: 6 citations2008: 7 citations2009: 10 citations2010: 25 citations2011: 68 citations2012: 87 citations2013: 102 citations2014: 116 citations2015: 112 citations2016: 140 citations2017: 116 citations2018: 161 citations2019: 543 citations2020: 733 citations2021: 778 citations2022: 796 citations2023: 614 citations2024: 1,202 citations2025: 710 citations2026: 11 citations1988–1995: no citations, so these years are not shown1997–1999: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 2,797 citing papers, 29% of this breakdownUnited States: 1,386 citing papers, 14.4% of this breakdownUnited Kingdom: 540 citing papers, 5.6% of this breakdownItaly: 365 citing papers, 3.8% of this breakdownAustralia: 290 citing papers, 3% of this breakdownGermany: 264 citing papers, 2.7% of this breakdownIndia: 264 citing papers, 2.7% of this breakdownCanada: 248 citing papers, 2.6% of this breakdownSpain: 189 citing papers, 1.9% of this breakdownHong Kong: 175 citing papers, 1.8% of this breakdownFrance: 170 citing papers, 1.8% of this breakdownSouth Korea: 170 citing papers, 1.8% of this breakdown
0%29%Other 28.9%

Institutions

Fields

  • Medicine70.2%
  • Biochemistry, Genetics and Molecular Biology18.2%
  • Immunology and Microbiology3.1%
  • Neuroscience1.2%
  • Health Professions1.1%
  • Nursing0.9%
  • Other5.3%

Topics

  • Diabetes Treatment and Management5.5%
  • Diabetes, Cardiovascular Risks, and Lipoproteins4.3%
  • Pancreatic function and diabetes3.3%
  • Diabetes Management and Research3.2%
  • Liver Disease Diagnosis and Treatment2.4%
  • Diabetes and associated disorders2.3%
  • Other79%

Coauthors

All papers

Open in search
  1. Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies

    Authors: Suowen Xu, Iqra Ilyas, Peter J. Little, Hong Li, Danielle Kamato, Xueying Zheng, Sihui Luo, Zhuoming Li, Peiqing Liu, Jihong Han, Ian C. Harding, Eno E. Ebong, Scott J. Cameron, Alastair G. Stewart, Jianping Weng - Pharmacological Reviews 2021 cited by 1,080

  2. Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies

    Authors: Xiumei Wu, Mengyun Xu, Mengya Geng, Shuo Chen, Peter J. Little, Suowen Xu, Jianping Weng - Signal Transduction and Targeted Therapy 2023 cited by 237

  3. GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential

    Authors: Xiaoxuan Ma, Zhenghong Liu, Iqra Ilyas, Peter J. Little, Danielle Kamato, Amirhossein Sahebka, Zhengfang Chen, Sihui Luo, Xueying Zheng, Jianping Weng, Suowen Xu - International Journal of Biological Sciences 2021 cited by 270

  4. Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies

    Authors: Suowen Xu, Iqra Ilyas, Jianping Weng - Acta Pharmacologica Sinica 2022 cited by 428

  5. Standards of medical care for type 2 diabetes in China 2019

    Authors: Weiping Jia, Jianping Weng, Dalong Zhu, Linong Ji, Juming Lu, Zhiguang Zhou, Dajin Zou, Lixin Guo, Qiuhe Ji, Li Chen, Liming Chen, Jingtao Dou, Xiaohui Guo, Hongyu Kuang, Ling Li, Qifu Li, Xiaoying Li, Jing Liu, Xingwu Ran, Lixin Shi, Guangyao Song, Xinhua Xiao, Liyong Yang, Zhigang Zhao, On behalf of Chinese Diabetes Society - Diabetes/Metabolism Research and Reviews 2019 cited by 763

  6. Mechanisms of Oxidized LDL-Mediated Endothelial Dysfunction and Its Consequences for the Development of Atherosclerosis

    Authors: Hui Jiang, Yongwen Zhou, Seyed Mohammad Nabavi, Amirhossein Sahebkar, Peter J. Little, Suowen Xu, Jianping Weng, Jianjun Ge - Frontiers in Cardiovascular Medicine 2022 cited by 292

  7. The role of inflammation in immune system of diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications

    Authors: Tong Yue, Yu Shi, Sihui Luo, Jianping Weng, Yali Wu, Xueying Zheng - Frontiers in Immunology 2022 cited by 194

  8. Prevalence of diabetic retinopathy and vision-threatening diabetic retinopathy in adults with diabetes in China

    Authors: Xuhong Hou, Limin Wang, Dalong Zhu, Lixin Guo, Jianping Weng, Mei Zhang, Zhiguang Zhou, Dajin Zou, Qiuhe Ji, Xiaohui Guo, Qiang Wu, Siyu Chen, Rong Yu, Hongli Chen, Zhengjing Huang, Xiao Zhang, Jiarui Wu, Jing Wu, Weiping Jia, Jing Wu, Weiping Jia, for the China National Diabetic Chronic Complications (DiaChronic) Study Group - Nature Communications 2023 cited by 128

  9. Liraglutide, Sitagliptin, and Insulin Glargine Added to Metformin: The Effect on Body Weight and Intrahepatic Lipid in Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease

    Authors: Jinhua Yan, Bin Yao, Hongyu Kuang, Xubin Yang, Qin Huang, Tianpei Hong, Yushu Li, Jingtao Dou, Wenying Yang, Guijun Qin, Huijuan Yuan, Xinhua Xiao, Sihui Luo, Zhongyan Shan, Hongrong Deng, Ying Tan, Fen Xu, Wen Xu, Longyi Zeng, Zhuang Kang, Jianping Weng - Hepatology 2018 cited by 252

  10. Resveratrol in Treating Diabetes and Its Cardiovascular Complications: A Review of Its Mechanisms of Action

    Authors: Meiming Su, Wenqi Zhao, Suowen Xu, Jianping Weng - Antioxidants 2022 cited by 108

  11. Prevalence of Diabetes among Men and Women in China

    Authors: Wenying Yang, Juming Lu, Jianping Weng, Weiping Jia, Linong Ji, Jianzhong Xiao, Zhongyan Shan, Jie Liu, Haoming Tian, Qiuhe Ji, Dalong Zhu, Jiapu Ge, Lixiang Lin, Li Chen, Xiaohui Guo, Zhigang Zhao, Qiang Li, Zhiguang Zhou, Guangliang Shan, Jiang He - New England Journal of Medicine 2010 cited by 3,055

  12. Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations

    Authors: Francesco Rubino, David M. Nathan, Robert H. Eckel, Philip R. Schauer, K. G. M. M. Alberti, Paul Zimmet, Stefano Del Prato, Linong Ji, S.M. Sadikot, William H. Herman, Stephanie A. Amiel, Lee M. Kaplan, Gaspar Taroncher‐Oldenburg, David E. Cummings, Delegates of the 2nd Diabetes Surgery Summit, Nizar Albache, Rachel L. Batterham, Deepak L. Bhatt, Camilo Boza, William T. Cefalu, Ricardo V. Cohen, Anita P. Courcoulas, Seán F. Dinneen, John B. Dixon, Ele Ferrannini, Paola Fioretto, Gema Frühbeck, Michel Gagner, Richard W. Grant, Sayeed Ikramuddin, Desmond G. Johnston, Sangeeta R. Kashyap, Tracy Kelly, Tomasz Klupa, Judith Körner, Blandine Laferrère, Harold E. Lebovitz, Wei‐Jei Lee, Carel W. le Roux, Jeffrey I. Mechanick, Geltrude Mingrone, John M. Morton, Walter J. Pories, Robert E. Ratner, Gerry Rayman, Harvey J. Sugerman, Luc Van Gaal, Josép Vidal, Jianping Weng, Bruce M. Wolfe - Diabetes Care 2016 cited by 971

  13. Kaempferol and atherosclerosis: From mechanism to medicine

    Authors: Meijie Chen, Jianbo Xiao, Hesham R. El‐Seedi, Krystyna Skalicka‐Woźniak, Maria Daglia, Peter J. Little, Jianping Weng, Suowen Xu - Critical Reviews in Food Science and Nutrition 2022 cited by 92

  14. The many faces of diabetes: a disease with increasing heterogeneity

    Authors: Tiinamaija Tuomi, Nicola Santoro, Sonia Caprio, Mengyin Cai, Jianping Weng, Leif Groop - The Lancet 2013 cited by 654

  15. Impact of sodium glucose cotransporter 2 (SGLT2) inhibitors on atherosclerosis: from pharmacology to pre-clinical and clinical therapeutics

    Authors: Zhenghong Liu, Xiaoxuan Ma, Iqra Ilyas, Xueying Zheng, Sihui Luo, Peter J. Little, Danielle Kamato, Amirhossein Sahebkar, Weiming Wu, Jianping Weng, Suowen Xu - Theranostics 2021 cited by 156

  16. Metformin, Macrophage Dysfunction and Atherosclerosis

    Authors: Xiaojun Feng, Wenxu Chen, Xiayun Ni, Peter J. Little, Suowen Xu, Liqin Tang, Jianping Weng - Frontiers in Immunology 2021 cited by 144

  17. Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review

    Authors: Fan-shun Zhang, Qing-ze He, Cheng Xue Qin, Peter J. Little, Jianping Weng, Suowen Xu - Acta Pharmacologica Sinica 2022 cited by 133

  18. Targeting FGF21 in cardiovascular and metabolic diseases: from mechanism to medicine

    Authors: Huiling Tan, Yue Tong, Zhengfang Chen, Weiming Wu, Suowen Xu, Jianping Weng - International Journal of Biological Sciences 2022 cited by 103

  19. Biochemical characterization of SARS-CoV-2 nucleocapsid protein

    Authors: Weihong Zeng, Guangfeng Liu, Huan Ma, Dan Zhao, Yunru Yang, Muziying Liu, Ahmed Mohammed, Changcheng Zhao, Yun Yang, Jiajia Xie, Chengchao Ding, Xiaoling Ma, Jianping Weng, Yong Gao, Hongliang He, Tengchuan Jin - Biochemical and Biophysical Research Communications 2020 cited by 527

  20. Mouse models of nonalcoholic fatty liver disease (NAFLD): pathomechanisms and pharmacotherapies

    Authors: Tingyu Fang, Hua Wang, Xiaoyue Pan, Peter J. Little, Suowen Xu, Jianping Weng - International Journal of Biological Sciences 2022 cited by 88

  21. TRIM56 protects against nonalcoholic fatty liver disease by promoting the degradation of fatty acid synthase

    Authors: Suowen Xu, Xiumei Wu, Sichen Wang, Mengyun Xu, Tingyu Fang, Xiaoxuan Ma, Meijie Chen, Jiajun Fu, Juan Guo, Song Tian, Tian Tian, Xu Cheng, Hailong Yang, Junjie Zhou, Zhenya Wang, Yanjun Yin, Wen Xu, Fen Xu, Jinhua Yan, Zhihua Wang, Sihui Luo, Xiao‐Jing Zhang, Yan‐Xiao Ji, Jianping Weng - Journal of Clinical Investigation 2024 cited by 58

  22. GLP-1 receptor agonist promotes brown remodelling in mouse white adipose tissue through SIRT1

    Authors: Fen Xu, Beisi Lin, Xiaobin Zheng, Zonglan Chen, Huanyi Cao, Haixia Xu, Hua Liang, Jianping Weng - Diabetologia 2016 cited by 148

  23. Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial

    Authors: Jianping Weng, Yanbing Li, Wen Xu, Lixin Shi, Qiao Zhang, Dalong Zhu, Yun Hu, Zhiguang Zhou, Xiang Yan, Haoming Tian, Xingwu Ran, Zuojie Luo, Jing Xian, Li Yan, Fangping Li, Longyi Zeng, Yanming Chen, Liyong Yang, Sunjie Yan, Juan Liu, Ming Li, FU Zu-zhi, Hua Cheng - The Lancet 2008 cited by 769

  24. Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort

    Authors: Roseanne O. Yeung, Yuying Zhang, Andrea O. Y. Luk, Wenying Yang, Leorino Sobrepeña, Kun‐Ho Yoon, S. R. Aravind, Wayne Huey‐Herng Sheu, Thy Khue Nguyen, Risa Ozaki, Chaicharn Deerochanawong, Chiu Chi Tsang, Wing-Bun Chan, Eun Gyoung Hong, Trung Quan, Yu Cheung, Nicola Brown, Su Yen Goh, Ronald C.W., M. Mukhopadhyay, Arvind Kumar Ojha, Shaibal Chakraborty, Alice P.S. Kong, Winnie Lau, Weiping Jia, Wenhui Li, Xiaohui Guo, Rongwen Bian, Jianping Weng, Linong Ji, Mercedes Reyes-dela Rosa, Ronaldo M Toledo, Thep Himathongkam, Soon-Jib Yoo, C. C. Chow, Larry L-T. Ho, Lee‐Ming Chuang, Greg Tutino, Peter C.Y. Tong, Wing‐Yee So, Troels Wolthers, Gary T.C. Ko, Greg Lyubomirsky, Juliana C.N. Chan - The Lancet Diabetes & Endocrinology 2014 cited by 302